LG
Lee Scott Golden
EVP & Chief Medical Officer

Lee Scott Golden insider trades: Ptc Therapeutics (PTCT) stock sales

EVP & Chief Medical Officer, Ptc Therapeutics Last trade Apr 2, 2026 19 Form 4 filings
$1.1M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2024
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lee reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 2, 2026PTCT↓ Sell$56K
Mar 5, 2026PTCT↓ Sell$634K
Feb 18, 2026PTCT↓ Sell$172K
Jan 8, 2026PTCT↓ Sell$66K
Jan 7, 2026PTCT↓ Sell$153K
Apr 2, 2025PTCT↓ Sell$42K
Feb 20, 2025PTCT↓ Sell$88K
Jan 8, 2025PTCT↓ Sell$90K
May 7, 2024PTCT↓ Sell$6K
Apr 2, 2024PTCT↓ Sell$15K
Jan 9, 2024PTCT↓ Sell$58K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PTCT insiders

Open-market trades in the last 12 months

About Lee Scott Golden's insider trades

Lee Scott Golden is EVP & Chief Medical Officer at Ptc Therapeutics (PTCT). Since Jan 9, 2024, Lee has reported no open-market purchases and 11 sales worth $1.4M on SEC Form 4. In the last 12 months: 5 sales ($1.1M).

Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.